How To Adapt Manufacturing To New Modalities And Methods

Despite incredible therapeutic innovations, the approach to manufacture life-changing drugs is stuck in the past. Today’s traditional manufacturing technology fails to serve all parts of a drug lifecycle, provides limited access to data, and requires extensive customization which further drains valuable resources. As the industry shifts toward more complex manufacturing processes with biologics and cell & gene therapies, there’s greater pressure to overcome these hurdles, allowing for greater production speed, reliability, drug quality, and safety.

In this keynote address, Apprentice.io CEO Angelo Stracquatanio took the audience on a journey through pharma’s current manufacturing technology, the industry’s growing challenges, and how organizations can remain competitive in a changing market.